Cargando…
1-{3-[(4-Oxopiperidin-1-yl)carbonyl]benzoyl}piperidin-4-one
Two independent molecules comprise the asymmetric unit in the title compound, C(18)H(20)N(2)O(4). One of the molecules exhibits disorder in one of its 4-piperidone rings, which is disposed over two orientations [site occupancy of the major component = 0.651 (5)]. The first independent molecule an...
Autores principales: | Rajesh, K., Vijayakumar, V., Sarveswari, S., Narasimhamurthy, T., Tiekink, Edward R. T. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
International Union of Crystallography
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3007266/ https://www.ncbi.nlm.nih.gov/pubmed/21588303 http://dx.doi.org/10.1107/S1600536810026681 |
Ejemplares similares
-
1-[2,4,6-Trimethyl-3,5-bis(4-oxopiperidin-1-ylmethyl)benzyl]piperidin-4-one
por: Rajesh, K., et al.
Publicado: (2010) -
(2E)-3-(4-Bromophenyl)-1-(2-methyl-4-phenyl-3-quinolyl)prop-2-en-1-one
por: Prasath, R., et al.
Publicado: (2010) -
(2E)-3-(4-Ethoxyphenyl)-1-(2-methyl-4-phenylquinolin-3-yl)prop-2-en-1-one monohydrate
por: Sarveswari, S., et al.
Publicado: (2010) -
tert-Butyl 4-{[5-(4-chlorophenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl]carbonyl}piperazine-1-carboxylate
por: Ragavan, R. Venkat, et al.
Publicado: (2010) -
1-{[5-(4-Chlorophenyl)-1-(4-fluorophenyl)-1H-pyrazol-3-yl]carbonyl]}piperidin-4-one
por: Shahani, Tara, et al.
Publicado: (2010)